简介：
Overview
This protocol outlines the preparation of high-quality PBMC and plasma biosamples for translational biomarker analysis in clinical trials. It emphasizes minimizing pre-analytical variability and is designed for ease of use in busy clinical settings.
Key Study Components
Area of Science
- Clinical trial methodology
- Biomarker analysis
- Oncology research
Background
- PBMC and plasma samples are critical in early clinical development.
- Robust protocols help reduce variability in sample preparation.
- Compatible with standard lab equipment and minimal expertise.
- Applicable across various disease areas and therapeutic modalities.
Purpose of Study
- To provide a reliable method for preparing PBMC and plasma samples.
- To support pharmacokinetic and pharmacodynamic studies.
- To facilitate analysis of drug mechanisms of action.
Methods Used
- Collection of blood samples and immediate processing.
- Centrifugation to separate plasma and PBMC layers.
- Storage of samples at appropriate temperatures for later analysis.
- Western blot analysis for protein expression studies.
Main Results
- Yield of PBMC varies based on patient and disease context.
- Post-translational modifications observed at different radiation doses.
- Phosphorylation changes suggest potential pharmacodynamic biomarkers.
- Optimal processing conditions enhance sample quality.
Conclusions
- This protocol is effective for preparing high-quality biosamples.
- It can be adapted for various clinical and research applications.
- Timely processing and correct centrifugation are crucial for quality.
What are PBMCs?
PBMCs, or peripheral blood mononuclear cells, are blood cells that have a round nucleus and include lymphocytes and monocytes.
Why is sample processing time critical?
Processing samples within one hour of collection minimizes degradation and variability, ensuring higher quality results.
What is the significance of post-translational modifications?
Post-translational modifications can indicate cellular responses to treatments and serve as biomarkers for drug efficacy.
How should samples be stored after preparation?
Samples should be stored at -80 degrees Celsius to preserve their integrity for future analysis.
Can this protocol be used for other diseases?
Yes, while designed for oncology studies, the protocol is applicable across various disease areas.
What equipment is needed for this protocol?
Basic lab equipment such as centrifuges, pipettes, and cryovials are sufficient for this protocol.
繁體中文
